Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Both GSK and Pfizer have been selling their holdings in Haleon at a fair clip. This month, Pfizer reduced its holding by 640m shares, selling them for ~$5.1 each for a total value of ~$2.43bn.

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Haleon backed its full-year guidance despite ... healthcare business—which was spun out of GSK and is partly owned by Pfizer—said Thursday that revenue for the quarter was 2.78 billion pounds ...

During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...

Recently, Pfizer has launched a specialised centre at a hospital in Gurugram and is planning to start more such centres to ...

NEW YORK, Nov 12 (Reuters) - Pfizer (PFE.N), opens new tab is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value ...